These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 4386118

  • 1. [Doxergan syrup in digestive complications of antitubercular treatment].
    Gunten JM.
    Praxis; 1967 Nov 09; 56(45):1535-7. PubMed ID: 4386118
    [No Abstract] [Full Text] [Related]

  • 2. [Trial of clinical evaluation of Doxergan, a new antihistaminic drug].
    Bogdaszewska-Czabanowska, Wiehler E.
    Przegl Dermatol; 1968 Nov 09; 55(3):349-55. PubMed ID: 4385459
    [No Abstract] [Full Text] [Related]

  • 3. [The antihistaminic Sandomigran as the treatment of choice in anxious, thin, and anorexic patients with migraine].
    Anselmi B, Del Bianco PL, Knor K, Sicuteri F.
    Schweiz Med Wochenschr; 1972 Apr 01; 102(13):487-91. PubMed ID: 4401762
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical study of a new antihistaminic in digestive disorders].
    Ahmadi N.
    Praxis; 1969 Mar 25; 58(12):381-4. PubMed ID: 4388667
    [No Abstract] [Full Text] [Related]

  • 6. [First clinical trails with the "medium tranquilizer" mesoridazine].
    Rhomberg F, Staehelin B.
    Schweiz Med Wochenschr; 1967 Apr 22; 97(16):521-5. PubMed ID: 4875573
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic results of dimethiothazine in various types of headache].
    Géraud J, Millet L.
    Therapie; 1966 Apr 22; 21(4):1019-27. PubMed ID: 4380820
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of functional cardiovascular and gastrointestinal disorders using NC-123].
    de Barros OM, Bourroul G.
    Hospital (Rio J); 1968 Sep 22; 74(3):955-62. PubMed ID: 5310131
    [No Abstract] [Full Text] [Related]

  • 9. Anti-nauseant drugs.
    Milton-Thompson GJ.
    Practitioner; 1979 Oct 22; 223(1336):516-9. PubMed ID: 42893
    [No Abstract] [Full Text] [Related]

  • 10. [A new drug (Migristene) with anti-serotonin and antihistaminic activity in the therapy of some gynecologic disorders].
    Bailo U, Finzi C.
    Minerva Ginecol; 1970 Apr 15; 22(7):395-7. PubMed ID: 4396482
    [No Abstract] [Full Text] [Related]

  • 11. [Our clinical experience with L 554 in gastroenterology].
    Dubarry J, Bernard JP.
    J Med Bord; 1966 May 15; 143(5):745-50. PubMed ID: 4380180
    [No Abstract] [Full Text] [Related]

  • 12. [Comparison of the adverse effects of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Rózewska M.
    Gruzlica; 1969 Dec 15; 37(12):1103-6. PubMed ID: 5368636
    [No Abstract] [Full Text] [Related]

  • 13. [Therapeutic experiences with a central sedative and peripheral analgesic-spasmolytic medication combination in gastrointestinal diseases].
    Lampe W.
    Med Welt; 1968 Jun 08; 23():1427-30. PubMed ID: 5718202
    [No Abstract] [Full Text] [Related]

  • 14. [Vomiting].
    Chirone E.
    Policlinico Prat; 1972 Jul 01; 79(13):557-60. PubMed ID: 4402858
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical study of metopimazine in gastroenterology].
    Herrera Ballester A, Tome Toyosato A, Medina Chulia E, González Muñoz C.
    Rev Esp Enferm Apar Dig; 1980 Jul 01; 58(1):41-6. PubMed ID: 6996058
    [No Abstract] [Full Text] [Related]

  • 16. [Dimethiotazine in migraine].
    Poch GF, Antonietti JN.
    Prensa Med Argent; 1970 Dec 25; 57(43):1977-80. PubMed ID: 4396442
    [No Abstract] [Full Text] [Related]

  • 17. [Aluminum and magnesium pentasilicates associated with pectin and sorbitol in gastrointestinal disorders observed in children during treatment by tuberculostatics].
    Gerbeaux J, Baculard A, Hanoteau J.
    Actual Hepatogastroenterol (Paris); 1968 Dec 25; 4(1):B23-4. PubMed ID: 5721702
    [No Abstract] [Full Text] [Related]

  • 18. [Gastrointestinal side-effects of antituberculosis drugs, especially a comparison between CMI level and side effects, and comparison of the side effects between 1321 TH and 1314 TH].
    Aoki M, Kihara K, Murase S, Hirasawa I.
    Kekkaku; 1969 Mar 25; 44(3):103-8. PubMed ID: 5783306
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of sodium oxyferriscorbone in cases of severe drug hypersensitivity].
    Kluz L, Zbikowski H.
    Gruzlica; 1969 Nov 25; 37(11):1003-6. PubMed ID: 4391678
    [No Abstract] [Full Text] [Related]

  • 20. [Benalgesic in the treatment of spastic dyskinesias of the digestive system in infants and children. Clinico-pharmacological considerations].
    Brunelli G.
    Minerva Pediatr; 1967 Oct 27; 19(43):1932-5. PubMed ID: 4387845
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.